Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Mucorales endocarditis is an extremely rare and devastating disease, with few cases reported in the literature. The infection is predominantly found in immunocompromised patients, although a few cases involving immunocompetent individuals have been reported. We reviewed all cases of mucor endocarditis reported to date with a focus on demographics, clinical presentations, and the range of predisposing conditions, including immunosuppressive states, recent surgery, and cardiac device implantation. The management included a combination of radical surgeries, systemic antifungal therapy, and, in some cases, lifelong suppressive oral antifungals. Despite such aggressive forms of treatment, the survival rate remained exceedingly low, reflecting the poor prognosis of this illness. The current review provides an insight into the clinical features, treatment challenges, and outcomes of mucor endocarditis to guide future diagnostic and therapeutic approaches.

Download full-text PDF

Source
http://dx.doi.org/10.1097/CRD.0000000000001026DOI Listing

Publication Analysis

Top Keywords

mucorales endocarditis
8
mucor endocarditis
8
endocarditis case
4
case series
4
series review
4
review literature
4
literature mucorales
4
endocarditis extremely
4
extremely rare
4
rare devastating
4

Similar Publications

Mucorales endocarditis is an extremely rare and devastating disease, with few cases reported in the literature. The infection is predominantly found in immunocompromised patients, although a few cases involving immunocompetent individuals have been reported. We reviewed all cases of mucor endocarditis reported to date with a focus on demographics, clinical presentations, and the range of predisposing conditions, including immunosuppressive states, recent surgery, and cardiac device implantation.

View Article and Find Full Text PDF

We report a rare case of aorto-bi-iliac prosthetic allograft mucormycosis in a 57-year-old immunocompetent patient in France. Outcome was favorable after surgery and dual antifungal therapy with liposomal amphotericin B and isavuconazole. In a literature review, we identified 12 other cases of prosthetic vascular or heart valve mucormycosis; mortality rate was 38%.

View Article and Find Full Text PDF

Fatal disseminated mucormycosis due to Cunninghamella bertholletiae infection after ABO-incompatible living donor liver transplantation: a case report.

Surg Case Rep

September 2022

Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.

Article Synopsis
  • Fungal infections can arise in organ transplant patients due to immunosuppression, with severe types like mucormycosis posing significant health risks.
  • A 47-year-old man received an ABO-incompatible liver transplant but later developed disseminated mucormycosis caused by Cunninghamella bertholletiae, leading to multiple organ complications.
  • Despite treatment efforts with amphotericin B, the patient suffered cardiac failure and ultimately died 27 days post-transplant, with autopsy findings showing widespread fungal invasion in various organs.
View Article and Find Full Text PDF

A 62-year-old female was presented to the hospital of the current study for pancytopenia and was diagnosed with severe aplastic anemia. She was treated with a combination therapy of antithymocyte globulin, cyclosporine A, and eltrombopag. The patient also presented with febrile neutropenia after commencement of the treatment and did not respond to the various antibiotics and antifungal agents.

View Article and Find Full Text PDF

spp. is a group of fungi belonging to the order. Cases of fungal endocarditis are sporadic, but more frequent in immunocompromised patients.

View Article and Find Full Text PDF